SymBiosis II LLC, major Clene (NASDAQ: CLNN) holder, sells 78,679 shares

Q: How many Clene Inc. (CLNN) shares were sold in the latest Form 4 filing?

The transactions show total open-market sales of 78,679 shares of Clene Inc. common stock. These were reported in two separate trades by SymBiosis II, LLC, acting as the indirect holder for ten percent owner Ugwumba Chidozie, during early May 2026.

Q: How many Clene Inc. (CLNN) shares does SymBiosis II, LLC hold after these sales?

Following the most recent reported transaction on May 4, 2026 , SymBiosis II, LLC held 198,890 shares of Clene Inc. common stock indirectly for Ugwumba Chidozie. This holding figure comes directly from the post-transaction ownership line in the filing.

Q: Are the Clene Inc. (CLNN) insider transactions direct or indirect holdings?

The filing classifies both transactions as indirect ownership. The nature of ownership is described as “By SymBiosis II, LLC,” meaning the common stock is held through this entity rather than directly in Ugwumba Chidozie’s personal name.

Q: What type of transactions were reported in Clene Inc. (CLNN)’s Form 4?

Both entries are coded “S” and described as open-market sales of Clene Inc. common stock. They involve non-derivative securities, indicating straightforward stock sales rather than option exercises or other derivative-related transactions.

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Clene Inc. insider activity: An entity associated with major shareholder Ugwumba Chidozie, identified as SymBiosis II, LLC, reported open-market sales of Clene Inc. common stock. On May 1, 2026, SymBiosis II, LLC sold 5,795 shares at $6.01 per share. On May 4, 2026, it sold an additional 72,884 shares at $6.80 per share. After the May 4 transaction, SymBiosis II, LLC continued to hold 198,890 shares of Clene Inc. common stock indirectly on behalf of Ugwumba Chidozie.

Insider Trade Summary

Net Seller: 78,679 shares ($530,439)

Net Sell 2 txns

Insider Ugwumba Chidozie

Role null

Sold 78,679 shs ($530K)

Type	Security	Shares	Price	Value
Sale	Common Stock	72,884	$6.80	$496K
Sale	Common Stock	5,795	$6.01	$35K

Holdings After Transaction: Common Stock — 198,890 shares (Indirect, By SymBiosis II, LLC)

Footnotes (1)

Key Figures

Shares sold May 4, 2026: 72,884 shares at $6.80 Shares sold May 1, 2026: 5,795 shares at $6.01 Total shares sold: 78,679 shares +2 more

5 metrics

Shares sold May 4, 2026 72,884 shares at $6.80 Open-market sale of Clene Inc. common stock by SymBiosis II, LLC

Shares sold May 1, 2026 5,795 shares at $6.01 Open-market sale of Clene Inc. common stock by SymBiosis II, LLC

Total shares sold 78,679 shares Aggregate open-market sales reported in the Form 4

Shares held after latest sale 198,890 shares Indirect ownership by SymBiosis II, LLC after May 4, 2026 trade

Ownership type Indirect (By SymBiosis II, LLC) Nature of ownership for all reported transactions

Key Terms

open-market sale, Common Stock, indirect, ten percent owner

4 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

indirect financial

"ownership_type: "indirect""

ten percent owner financial

""is_ten_percent_owner": 1"

Form 4 Insider Transactions: What Each Field Means →

05/05/2026 - 05:53 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ugwumba Chidozie

(Last)

(First)

(Middle)

609 SW 8TH STREET

SUITE 510

(Street)

BENTONVILLE

ARKANSAS

72712

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/01/2026		S		5,795	D	$6.01	271,774	I	By SymBiosis II, LLC
Common Stock	05/04/2026		S		72,884	D	$6.8	198,890	I	By SymBiosis II, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

	/s/ Chidozie Ugwumba	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Clene Inc. (CLNN) report for Ugwumba Chidozie?

The filing reports that SymBiosis II, LLC, an entity associated with ten percent owner Ugwumba Chidozie, executed two open-market sales of Clene Inc. common stock, totaling 78,679 shares, and continued to hold 198,890 shares indirectly after the latest transaction.

How many Clene Inc. (CLNN) shares were sold in the latest Form 4 filing?

The transactions show total open-market sales of 78,679 shares of Clene Inc. common stock. These were reported in two separate trades by SymBiosis II, LLC, acting as the indirect holder for ten percent owner Ugwumba Chidozie, during early May 2026.

At what prices were Clene Inc. (CLNN) shares sold in this insider filing?

SymBiosis II, LLC reported selling Clene Inc. common stock at $6.01 per share on May 1, 2026 and at $6.80 per share on May 4, 2026. Both trades were classified as open-market sales of common stock.

How many Clene Inc. (CLNN) shares does SymBiosis II, LLC hold after these sales?

Following the most recent reported transaction on May 4, 2026, SymBiosis II, LLC held 198,890 shares of Clene Inc. common stock indirectly for Ugwumba Chidozie. This holding figure comes directly from the post-transaction ownership line in the filing.

Are the Clene Inc. (CLNN) insider transactions direct or indirect holdings?

The filing classifies both transactions as indirect ownership. The nature of ownership is described as “By SymBiosis II, LLC,” meaning the common stock is held through this entity rather than directly in Ugwumba Chidozie’s personal name.

What type of transactions were reported in Clene Inc. (CLNN)’s Form 4?

Both entries are coded “S” and described as open-market sales of Clene Inc. common stock. They involve non-derivative securities, indicating straightforward stock sales rather than option exercises or other derivative-related transactions.